Crosstalk of intracellular post-translational modifications in cancer
- PMID: 31606391
- DOI: 10.1016/j.abb.2019.108138
Crosstalk of intracellular post-translational modifications in cancer
Abstract
Post-translational modifications (PTMs) have been reported to play pivotal roles in numerous cellular biochemical and physiological processes. Multiple PTMs can influence the actions of each other positively or negatively, termed as PTM crosstalk or PTM code. During recent years, development of identification strategies for PTMs co-occurrence has revealed abundant information of interplay between PTMs. Increasing evidence demonstrates that deregulation of PTMs crosstalk is involved in the genesis and development of various diseases. Insight into the complexity of PTMs crosstalk will help us better understand etiology and provide novel targets for drug therapy. In the present review, we will discuss the important functional roles of PTMs crosstalk in proteins associated with cancer diseases.
Keywords: Cancer-related proteins; Drug target; PTMs crosstalk; Tumorigenesis.
Copyright © 2019 Elsevier Inc. All rights reserved.
Similar articles
-
Crosstalk between phosphorylation and O-GlcNAcylation: friend or foe.FEBS J. 2018 Sep;285(17):3152-3167. doi: 10.1111/febs.14491. Epub 2018 May 13. FEBS J. 2018. PMID: 29717537 Review.
-
The next level of complexity: crosstalk of posttranslational modifications.Proteomics. 2014 Mar;14(4-5):513-24. doi: 10.1002/pmic.201300344. Epub 2014 Jan 6. Proteomics. 2014. PMID: 24339426 Review.
-
Pathological implication of protein post-translational modifications in cancer.Mol Aspects Med. 2022 Aug;86:101097. doi: 10.1016/j.mam.2022.101097. Epub 2022 Apr 7. Mol Aspects Med. 2022. PMID: 35400524 Free PMC article. Review.
-
Crosstalk between Ubiquitination and Other Post-translational Protein Modifications in Plant Immunity.Plant Commun. 2020 Mar 25;1(4):100041. doi: 10.1016/j.xplc.2020.100041. eCollection 2020 Jul 13. Plant Commun. 2020. PMID: 33367245 Free PMC article. Review.
-
Protein Post-Translational Modification Crosstalk in Acute Myeloid Leukemia Calls for Action.Curr Med Chem. 2019;26(28):5317-5337. doi: 10.2174/0929867326666190503164004. Curr Med Chem. 2019. PMID: 31241430 Review.
Cited by
-
Tumor immune checkpoints and their associated inhibitors.J Zhejiang Univ Sci B. 2022 Oct 15;23(10):823-843. doi: 10.1631/jzus.B2200195. J Zhejiang Univ Sci B. 2022. PMID: 36226537 Free PMC article. Review.
-
Proton pump inhibitors stabilize the expression of PD-L1 on cell membrane depending on the phosphorylation of GSK3β.Cancer Med. 2024 May;13(10):e7083. doi: 10.1002/cam4.7083. Cancer Med. 2024. PMID: 38752436 Free PMC article.
-
Regulation of PD-L1 expression in the tumor microenvironment.J Hematol Oncol. 2021 Jan 7;14(1):10. doi: 10.1186/s13045-020-01027-5. J Hematol Oncol. 2021. PMID: 33413496 Free PMC article. Review.
-
Roles of posttranslational modifications in lipid metabolism and cancer progression.Biomark Res. 2024 Nov 18;12(1):141. doi: 10.1186/s40364-024-00681-y. Biomark Res. 2024. PMID: 39551780 Free PMC article. Review.
-
Identification of the consistently differential expressed hub mRNAs and proteins in lung adenocarcinoma and construction of the prognostic signature: a multidimensional analysis.Int J Surg. 2024 Feb 1;110(2):1052-1067. doi: 10.1097/JS9.0000000000000943. Int J Surg. 2024. PMID: 38016140 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Miscellaneous